XML 77 R55.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Additional Financial Information (Tables)
 12 Months Ended
Jun. 30, 2024
Additional Financial Information [Abstract]  
Cash, Cash Equivalents and Restricted Cash
The following table provides a summary of the amounts recorded as cash and cash equivalents, and restricted cash as of June 30, 2024 and 2023:
As of June 30,
20242023
Cash and cash equivalents$559,757 $131,965 
Restricted cash$13,476 $297,149 
Total Cash and cash equivalents, and restricted cash
$573,233 $429,114 
Schedule of Cash and Cash Equivalents
The following table provides a summary of the amounts recorded as cash and cash equivalents, and restricted cash as of June 30, 2024 and 2023:
As of June 30,
20242023
Cash and cash equivalents$559,757 $131,965 
Restricted cash$13,476 $297,149 
Total Cash and cash equivalents, and restricted cash
$573,233 $429,114 
Schedule of Other Current Assets
Prepaid expenses and other current assets as of June 30, 2024 and 2023 consisted of the following:
As of June 30,
20242023
Prepaid expenses$30,864 $23,450 
Note and other receivables3,866 21,453 
Inventory11,893 — 
Current deferred production costs2,094 6,524 
Other6,138 4,658 
Total prepaid expenses and other current assets$54,855 $56,085 
Other Current Liabilities
Accounts payable, accrued, and other current liabilities as of June 30, 2024 and 2023 consisted of the following:
As of June 30,
20242023
Accounts payable$18,875 $39,654 
Accrued payroll and employee related liabilities85,766 75,579 
Cash due to promoters72,577 73,611 
Capital expenditure accruals156,234 236,593 
Accrued legal fees20,876 53,857 
Other accrued expenses62,759 36,437 
Total accounts payable, accrued, and other current liabilities$417,087 $515,731 
Schedule of Other Nonoperating Income (Expense)
Other income (expense), net for Fiscal Years 2024, 2023 and 2022 included the following:
Years Ended June 30,
202420232022
Realized and unrealized (loss) gain on MSGE Retained Interest, see Note 7 for further detail
$(19,027)$545,715 $— 
Gain on litigation settlement62,647 — — 
Unrealized gain on equity investments without readily determinable fair value— 1,969 — 
Loss on equity method investments
(6,677)(8,184)(4,863)
Other(1,746)(2,613)(655)
Total other income (expense), net$35,197 $536,887 $(5,518)